Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Net Income (2018 - 2025)

Health Catalyst (HCAT) has disclosed Net Income for 8 consecutive years, with -$22.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Net Income fell 50.95% year-over-year to -$22.2 million, compared with a TTM value of -$107.6 million through Sep 2025, down 35.91%, and an annual FY2024 reading of -$69.5 million, up 41.2% over the prior year.
  • Net Income was -$22.2 million for Q3 2025 at Health Catalyst, up from -$41.0 million in the prior quarter.
  • Across five years, Net Income topped out at -$13.5 million in Q2 2024 and bottomed at -$49.0 million in Q4 2021.
  • Average Net Income over 5 years is -$29.8 million, with a median of -$30.4 million recorded in 2023.
  • The sharpest move saw Net Income surged 58.56% in 2024, then crashed 203.18% in 2025.
  • Year by year, Net Income stood at -$49.0 million in 2021, then increased by 26.96% to -$35.8 million in 2022, then grew by 15.16% to -$30.4 million in 2023, then skyrocketed by 31.9% to -$20.7 million in 2024, then dropped by 7.53% to -$22.2 million in 2025.
  • Business Quant data shows Net Income for HCAT at -$22.2 million in Q3 2025, -$41.0 million in Q2 2025, and -$23.7 million in Q1 2025.